We downloaded the microarray expression profile between CAD patients and control sample from the GEO database and identified three genes (ASCC2, LRRC18 and SLC25A37) as key genes in CAD via integrated bioinformatics analysis. Here, SLC25A37 is linked to coronary artery disorder.